Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Advanced NSCLC (BAC or Non-Smokers)
NCT00073008Phase 2Terminated
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lapatinib in non-small cell lung cancer (NSCLC), sponsored by GSK. Started Nov 2003; status: terminated.
02
Drugs
lapatinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00073008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073008.